European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.
| Preview | Title | Contact |
|---|---|---|
|
PDF (risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)
- Published Version
1MB |
This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, that was conducted by the Scientific Committee of the EMCDDA. Concerns over this issociative drug in the European Union led to an assessment of the health and social risks posed by the substance in April 2014.
Methoxetamine is an arylcyclohexylamine substance which is chemically similar to ketamine and PCP and in common with these, has dissociative properties.
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
MM-MO Crime and law > Substance use laws > Drug laws
VA Geographic area > Europe
Repository Staff Only: item control page